Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody.


Journal

Journal of neuroimmunology
ISSN: 1872-8421
Titre abrégé: J Neuroimmunol
Pays: Netherlands
ID NLM: 8109498

Informations de publication

Date de publication:
15 12 2020
Historique:
received: 06 10 2020
revised: 24 10 2020
accepted: 26 10 2020
pubmed: 5 11 2020
medline: 17 12 2020
entrez: 4 11 2020
Statut: ppublish

Résumé

This study aimed to determine the seasonal impact on the clinical onset of inflammatory neurological diseases of the central nervous system by analyzing the onset month with information on clinical manifestations in Japanese patients. As a result, patients with anti-aquaporin-4 antibodies (AQP4-IgG)-positive neuromyelitis optica spectrum disorders (NMOSD) showed spring-summer predominance of the clinical onset. Conversely, patients with anti-myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease showed autumn-winter predominance of the clinical onset. Both seasonal variations were irrespective of the clinical manifestation. Environmental factors with seasonal variation influence the development of neurological conditions related to AQP4-IgG and MOG-IgG.

Identifiants

pubmed: 33147540
pii: S0165-5728(20)30692-5
doi: 10.1016/j.jneuroim.2020.577431
pii:
doi:

Substances chimiques

AQP4 protein, human 0
Aquaporin 4 0
Autoantibodies 0
MOG protein, human 0
Myelin-Oligodendrocyte Glycoprotein 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

577431

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Tetsuya Akaishi (T)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, Japan. Electronic address: t-akaishi@med.tohoku.ac.jp.

Juichi Fujimori (J)

Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Toshiyuki Takahashi (T)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Yonezawa National Hospital, Yonezawa, Japan.

Tatsuro Misu (T)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yoshiki Takai (Y)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Shuhei Nishiyama (S)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Kimihiko Kaneko (K)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Ryo Ogawa (R)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Michiaki Abe (M)

Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, Japan.

Tadashi Ishii (T)

Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, Japan.

Masashi Aoki (M)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Kazuo Fujihara (K)

Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Fukushima, Japan.

Ichiro Nakashima (I)

Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH